Furst D E, Tozer T N, Melmon K L
Clin Pharmacol Ther. 1979 Sep;26(3):380-9. doi: 10.1002/cpt1979263380.
Steady-state plasma salicylate concentrations and protein binding were examined in 9 normal subjects to determine relationships among daily dose, total and unbound salicylate concentrations, and total and unbound clearances. Aspirin doses ranging from 0.66 to 4.0 mg/kg/hr were given to steady state. Free and total salicylate concentrations were measured with spectrophotometric, fluorimetric, and equilibrium dialysis techniques. Although unbound clearance decreased over the therapeutic range, total clearance was unchanged. The former is a consequence of saturable metabolism; the latter, of saturable plasma protein binding as well as saturable metabolism. The fraction unbound increased linearly with unbound concentration. Clearance determined at 1.8 mg/kg/hr was used to predict levels obtained at higher aspirin doses. Analysis of residuals was used to ascertain the accuracy of the prediction. The coefficient of variation from prediction among subjects was found to be +/- 14%. It is concluded that, in normal subjects, salicylate clearance changes relatively little over the therapeutic range because the increasing fraction unbound compensates for decreasing clearance of unbound drug.
对9名正常受试者的稳态血浆水杨酸盐浓度和蛋白结合情况进行了检测,以确定日剂量、总水杨酸盐浓度和游离水杨酸盐浓度以及总清除率和游离清除率之间的关系。给予阿司匹林的剂量范围为0.66至4.0毫克/千克/小时,直至达到稳态。采用分光光度法、荧光法和平衡透析技术测量游离和总水杨酸盐浓度。尽管游离清除率在治疗范围内降低,但总清除率保持不变。前者是可饱和代谢的结果;后者则是可饱和血浆蛋白结合以及可饱和代谢的结果。游离分数随游离浓度呈线性增加。以1.8毫克/千克/小时时测定的清除率来预测更高阿司匹林剂量时的水平。采用残差分析来确定预测的准确性。发现受试者之间预测的变异系数为±14%。得出的结论是,在正常受试者中,水杨酸盐清除率在治疗范围内变化相对较小,因为游离分数的增加补偿了游离药物清除率的降低。